Investigative Medicine Division
We aim to rapidly translate innovative science into patient benefit across a range of disease areas. From molecular biology and target discovery, through to interventional medicine and informing policy, we bring together researchers in a diverse range of specialties including acute stroke, dementia and immunology.
Head of Division
Latest publications
-
Temporal changes in erythroid progenitors in critically ill patients: a prospective cohort study
Journal article
Scott C. et al, (2024), Haematologica
-
Development of a recombinant non-replicating Newcastle disease virus.
Journal article
Cheow P-S. et al, (2024), Avian Pathol, 1 - 9
-
Safety in spinal surgery—Empowering clinicians to report concerns in motor function
Journal article
Burrows J. et al, (2024), Journal of Advanced Nursing
-
The iron curve: infection at both ends.
Journal article
Drakesmith H. and Zoller H., (2024), Blood, 144, 679 - 680
-
Structure of a fully assembled γδ T-cell antigen receptor.
Journal article
Gully BS. et al, (2024), Nature
COVID-19 research
Novel all-in-one vaccine developed to tackle future coronavirus threats
6 July 2022
Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.
Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease
1 December 2021
Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.
What's new
Welcome to the new RDM Visiting Professors
27 November 2023